| Phase 4 |
| NCT07074418 |
Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2 |
Chronic Kidney Diseases |
Recruiting |
2026-09-10 |
| NCT07072988 |
Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia… |
Myasthenia Gravis, Generalized |
Recruiting |
2026-09-03 |
| NCT06541535 |
Fluid Administration in Ketoacidosis (DRINK) |
Diabetic Keto-acidosis |
Recruiting |
2026-05-26 |
| NCT05821517 |
METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the… |
Anterior Shoulder Dislocation |
Recruiting |
2025-12-04 |
| NCT04925414 |
Migraine and High Flow Oxygenotherapy at the Emergency Department (MiOx) |
Migraine |
Recruiting |
2024-11-18 |
| NCT07582185 |
Tdose Binding and Tocilizumab |
Rheumatoid Arthritis |
Not Yet Recruiting |
2026-05-12 |
| NCT04829565 |
Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal… |
Rhizarthrosis |
Active, Not Recruiting |
2025-12-03 |
| NCT04406259 |
Atrioventricular Block and Cluster Headache (SEVA) |
Cluster Headache |
Active, Not Recruiting |
2025-12-02 |
| Phase 3 |
| NCT06447480 |
Clinical Trial to Compare Oral Isotretinoin to Standard of Care in Moderate Acne Skin of… |
Acne Vulgaris |
Recruiting |
2026-10-01 |
| NCT05902221 |
Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint… |
Infections Joint Prosthetic |
Recruiting |
2026-06-22 |
| NCT06341205 |
Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous… |
Membranous Nephropathy |
Recruiting |
2026-06-22 |
| NCT05210621 |
LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB |
Multiple Sclerosis |
Active, Not Recruiting |
2024-05-17 |
| Phase 2/3 |
| NCT07501507 |
Methotrexate Treatment in Hand Osteoarthritis Refractory to Usual Treatments |
Erosive Hand Osteoarthritis |
Recruiting |
2026-09-24 |
| NCT07557693 |
Mitochondrial Network Modulation Approach Using Hyperbaric Oxygen (HBO) Therapy and… |
Vitiligo Vulgaris |
Not Yet Recruiting |
2026-06-05 |
| Phase 2 |
| NCT06742333 |
Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation? |
Psoriasis |
Recruiting |
2026-10-01 |
| NCT07492251 |
Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen… |
Lichen Penis Planus |
Recruiting |
2026-10-01 |
| NCT06112522 |
Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma |
Cell Carcinoma |
Recruiting |
2026-06-22 |
| NCT07152626 |
Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for… |
Vitiligo |
Recruiting |
2026-05-20 |
| NCT05260528 |
CPX-351 vs Intensive Chemotherapy in Patients With de Novo Intermediate or Adverse Risk… |
Acute Myeloid Leukemia |
Recruiting |
2026-03-27 |
| NCT04063540 |
Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of… |
Migraine With Aura |
Recruiting |
2025-12-04 |
| NCT06136403 |
A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in… |
Epidermolysis Bullosa Simplex |
Recruiting |
2025-08-05 |
| NCT06509984 |
A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex… |
Epidermolysis Bullosa Simplex |
Recruiting |
2025-02-24 |
| NCT07096986 |
Impact of Dapagliflozin for the Regulation of Immunological Activity in Membranous… |
Glomerulonephritis |
Not Yet Recruiting |
2026-06-22 |
| NCT06327321 |
Vitiligo Treatment by Targeting TYK2 Mediated Responses |
Vitiligo, Generalized |
Active, Not Recruiting |
2026-05-20 |
| NCT06222827 |
Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1 |
Facioscapulohumeral Muscular Dystrophy 1 |
Active, Not Recruiting |
2025-03-26 |